InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Raday Gilead. Director active across 1 company, notably RedHill Biopharma Ltd.. Cumulatively, 2 disclosures have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €3k. Activity tracked since 6 April 2026. The latest transaction was disclosed on 10 July 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations